Major US medical organisations are asking a federal judge in Boston to urgently block new federal guidance that reduces the number of vaccines routinely recommended for children. The debate centres on whether changes to the US Childhood Vaccine Schedule by the administration could impact public health.
In addition, the case is shaping up as a pivotal test of how far the Trump administration can go in remaking national immunisation policy under Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.
Lawyers for the American Academy of Paediatrics and other groups told US District Judge Brian Murphy that the government acted unlawfully and jeopardised public health. They argued that the changes will confuse parents and clinicians, depress uptake, and weaken protection against preventable disease. One lawyer described the situation as a “clear and present danger” to public health.
Childhood Vaccine Schedule: What Changed In January
A new CDC immunisation schedule, issued on 5 January 2026, sits at the centre of the Childhood Vaccine Schedule Lawsuit. The guidance reduced the number of childhood vaccinations classed as “routinely recommended” to 11 and downgraded several others.
The medical groups say this shift removed broad recommendations for vaccines covering diseases such as rotavirus, seasonal influenza, and hepatitis A. Instead, the CDC moved some immunisations to a “shared clinical decision-making” model. This recommendation advises parents to discuss risks and benefits with a clinician rather than follow population-level guidelines. The government has said insurers would continue to cover the shots.
For health systems, the worry is not only clinical. Routine recommendations often act as the default for reminders, quality measures, school and childcare expectations, and day-to-day workflow in primary care. As a result, any ambiguity can ripple through scheduling, counselling time, and vaccine ordering.
Fight Over the Advisory Panel
The plaintiffs also want the judge to stop the CDC’s influential vaccine advisory committee, the Advisory Committee on Immunisation Practices (ACIP), from holding its next meeting on 26–27 February. They argue that Kennedy's removal and replacement of all 17 members left the panel improperly constituted. Furthermore, they claim that people aligned with anti-vaccine views dominate the re-made committee, violating federal requirements for advisory panels to remain fairly balanced and free from inappropriate influence.
Judge Murphy appeared open to arguments that the panel could be unlawful and asked whether the court could consider broader public health impacts. He did not rule immediately, noting the case is moving on a tight timeline given the upcoming meeting.
What the Government is Saying
The US Department of Justice argued the agency has broad authority to adjust vaccine policy. Government lawyers said HHS is not pursuing an anti-vaccine agenda and framed the changes as part of restoring public trust after the COVID-19 pandemic.
A ruling could set the tone for how quickly federal health agencies can reshape clinical “defaults” without the usual advisory processes. For providers, payers and public health leaders, the practical issue is certainty: what gets recommended, how it gets coded, and what families hear in the consulting room.